Anti-Foxo6 (phospho S184) antibody [EPR6863]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal FOXO6 phospho S184 antibody. Suitable for WB and reacts with Rat samples. Cited in 1 publication.
View Alternative Names
Forkhead box protein O6, FOXO6
- WB
Unknown
Western blot - Anti-Foxo6 (phospho S184) antibody [EPR6863] (AB154832)
All lanes:
Western blot - Anti-Foxo6 (phospho S184) antibody [EPR6863] (ab154832) at 1/1000 dilution
Lane 1:
Rat brain lysate, untreated at 10 µg
Lane 2:
Rat brain lysate, treated with AP at 10 µg
Predicted band size: 61 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The regulatory activity of Foxo6 is important for maintaining neural integrity and proper brain function. It does not work as part of a larger complex but influences the expression of genes involved in cell cycle arrest longevity and stress resistance. Researchers have observed Foxo6 activity to affect synaptic function and plasticity in neurons which are critical for learning and memory processes. Its role in transcriptional regulation highlights its significance in managing cellular homeostasis and response to environmental changes.
Pathways
Foxo6 acts within the insulin signaling and PI3K/AKT pathways which are central to regulating growth proliferation and survival. Through these pathways Foxo6 interacts with proteins like AKT1 and 14-3-3 which modulate its activity by nuclear-cytoplasmic shuttling or degradation. The balance of Foxo6 activity within these pathways influences how cells respond to insulin and manage oxidative stress linking it to metabolic and stress response processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Cell reports 19:1858-1873 PubMed28564604
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com